Developer docs
API playgroundTry for free, no card

Search company profiles

Akumin

Full company profile

uuid0002h36

Namestring
Akumin
Legal namestring
Akumin Inc.
Websiteurl
akumin.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Akumin Inc. is a U.S. national provider of outpatient diagnostic imaging and radiation therapy services, headquartered in Tampa, Florida, and operating as a privately held company following its delisting from the TSX. The company runs 124 fixed-site outpatient imaging centers across 14 states, the nation's largest mobile imaging fleet, and the Akumin AXIS line of relocatable imaging suites (including a 1.5T MRI and a patent-pending mobile PET/CT Drop Trailer), partnering with more than 800 hospitals, health systems, and physician groups. Service offerings span MRI (wide-bore, open, upright, and specialty exams), PET/CT (including PSMA PET/CT for prostate cancer), CT, digital X-ray, ultrasound (including echocardiography and TRUS), 3D mammography, nuclear medicine, DEXA bone density, MRA, calcium scoring, and EKG, along with radiation therapy/oncology delivered in outpatient settings.

The business is built on a hybrid B2B/B2C model. Akumin generates revenue from per-exam imaging and radiation therapy services billed primarily through insurance reimbursement at its fixed-site centers, from mobile imaging services deployed to partner facilities, and from enterprise partner solutions structured as joint ventures, managed services, interim/mobile arrangements, oncology services, and urology solutions (mobile PET/CT, MRI, radiopharmaceuticals, and staffing). Customer segments are hospitals and health systems seeking to expand imaging capacity without capital outlay, physician groups requiring diagnostic capability for their patients, and individual patients accessing outpatient imaging directly. Supporting infrastructure includes a physician portal for electronic order and results management, an EMR-agnostic interoperability stack (HL7, Direct Messaging, PowerShare cloud image exchange, Athenahealth integration, and lightweight installer tools), and RadSite standards committee participation for accreditation.

Operationally, Akumin has been in a financial restructuring phase: in late 2025, Stonepeak committed a $154.5 million investment to support an exchange offer for 2027 and 2028 senior secured notes, extend maturities, and provide new growth capital, with over 99% of noteholders tendering by the February 2026 early deadline. The company is pairing this balance sheet repair with the commercial launch of the Akumin AXIS relocatable imaging line, deepened technology partnership with Siemens Healthineers, and continued integration into cloud-based EMR and image exchange ecosystems, positioning it as a turnaround-stage national outpatient imaging platform rather than an early-stage growth company.

Short descriptiontext

Akumin Inc. is a U.S. national outpatient diagnostic imaging and radiation therapy provider operating 124 fixed-site centers across 14 states, the nation's largest mobile imaging fleet, and the Akumin AXIS relocatable imaging line, serving 800+ hospitals, health systems, physician groups, and individual patients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersJenkintown, United States
HQ citystring
Jenkintown
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
outpatient diagnostic imaging, radiation therapy services, medical imaging centers, mobile imaging fleet, oncology treatment services
Industry4 codes
1Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology)
CodeHLAFAKABPrimaryYes
2Radiology Imaging Centers (X-ray/CT/MRI/Ultrasound)
CodeHLAFAKAAPrimaryNo
3Nuclear Medicine Clinical Services & Therapy Centers
CodeHLAIAGAIPrimaryNo
4Image Exchange, Sharing & Patient/Provider Portals (DICOM/Web)
CodeHLACALAIPrimaryNo
NAICS code2 codes
  • Diagnostic Imaging Centers621512
  • Ambulatory Health Care Services621
SIC code2 codes
  • Services-Specialty Outpatient Facilities, Nec8093
  • Services-Health Services8000
Product category
Outpatient Diagnostic Imaging Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Diagnostic Imaging Services
TypeSubscription Recurring
Description

Revenue generated from providing advanced diagnostic imaging services including MRI, PET/CT, CT, X-ray, Nuclear Medicine, DEXA, and 3D Mammography through fixed-site outpatient centers and mobile units

akumin.com
2Radiation Therapy / Oncology Services
TypeSubscription Recurring
Description

Comprehensive oncology and radiation therapy solutions for cancer treatment delivered in outpatient settings

akumin.com
3Partner Solutions
TypeManaged Services
Description

Revenue from joint ventures, managed services, interim & mobile solutions, and urology solutions offered to hospitals, health systems, and physician groups

akumin.com
4Mobile Imaging Services
TypeSubscription Recurring
Description

Revenue from mobile imaging fleet providing flexible diagnostic imaging solutions across multiple locations

akumin.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 record
1Akumin AXIS
Description

Relocatable imaging suite line featuring mobile MRI and PET/CT units including the Akumin AXIS 1.5T MRI with Siemens Healthineers Magnetom Viato technology and the patent-pending Akumin AXIS Drop Trailer mobile imaging unit.

businesswire.com
Core offering1 text field

Akumin owns and operates a national network of 124 outpatient diagnostic imaging centers across 14 US states, complemented by the nation's largest mobile imaging fleet and Akumin AXIS relocatable clinics. The company delivers advanced diagnostic imaging (MRI, PET/CT, CT, X-ray, Nuclear Medicine, DEXA, 3D Mammography) and radiation therapy/oncology services, partnering with more than 800 hospitals, health systems, and physician groups through joint ventures, managed services, and interim & mobile solutions.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Akumin is a national provider of outpatient diagnostic imaging and radiation therapy/oncology services, operating a unified platform of owned and/or managed outpatient imaging centers, the nation's largest mobile imaging fleet, and Akumin AXIS relocatable clinics — partnering with over 800 hospitals, health systems, and physician groups. The product portfolio is organized around three core service pillars: Radiology Procedures (MRI/PET-CT/CT/X-ray/Nuclear Medicine/DEXA/3D Mammography), Oncology Treatment (radiation therapy), and Partner Solutions (joint ventures, managed services, interim & mobile solutions, oncology services, urology solutions). Akumin AXIS is the company's relocatable imaging suite sub-brand offering fixed relocatable MRI (1.5T Siemens Healthineers) and the patent-pending Drop Trailer mobile PET/CT unit. Supporting infrastructure includes a Physician Portal for order and results management, PowerShare cloud image exchange integration, and interoperability options spanning HL7, Direct Messaging, Athenahealth EMR, and lightweight installer tools. Akumin also participates in RadSite's accreditation programs for advanced diagnostic imaging quality and safety standards.

Product and service17 records
1Akumin AXIS
CategoryMobile Imaging Equipment
Description

Relocatable imaging suite line offering mobile and modular imaging solutions, including fixed relocatable 1.5T MRI units and the patent-pending Drop Trailer mobile PET/CT unit with step-free patient access, designed for direct hospital deployment.

2PET/CT Imaging
CategoryDiagnostic Radiology
Description

Positron Emission Tomography and Computed Tomography combined in a single exam, providing both metabolic and anatomical information. Includes standard PET/CT and PSMA PET/CT for prostate cancer detection, offered across fixed-site and mobile/network locations.

3MRI (Magnetic Resonance Imaging)
CategoryDiagnostic Radiology
Description

Diagnostic imaging using radio waves and a strong magnetic field to visualize internal organs without ionizing radiation. Includes Wide-Bore MRI (1.5T-3T), Open MRI, Upright MRI, prostate MRI, cardiac MRI, and NeuroQuant brain MRI analysis.

43D Mammography (Breast Tomosynthesis)
CategoryWomen's Imaging
Description

FDA-approved breast imaging technology that captures multiple slices of the breast at various angles and reconstructs them into a 3D image, improving cancer detection over standard 2D mammography. Offered as screening and diagnostic mammograms.

5CT Scan (Computed Tomography)
CategoryDiagnostic Radiology
Description

Diagnostic imaging combining X-ray technology with computer processing to generate detailed cross-sectional images of the body for head/neck, chest, abdomen/pelvis, musculoskeletal, oncology, cardiac (CCTA), and low-dose lung screening applications.

6Digital X-ray
CategoryDiagnostic Radiology
Description

General radiography providing quick imaging for chest, abdominal, KUB, neck, hand, joint, and skull exams.

7Ultrasound
CategoryDiagnostic Radiology
Description

Imaging using high-frequency sound waves to create real-time pictures of internal organs and blood vessels, applied in prenatal care, abdominal, pelvic, vascular, cardiac, and procedure guidance contexts.

8Echocardiography
CategoryDiagnostic Cardiology
Description

Ultrasound scan of the heart and surrounding blood vessels, including transthoracic (TTE), transesophageal (TEE), Doppler, and color Doppler assessments of blood flow.

9Electrocardiography (EKG/ECG)
CategoryDiagnostic Cardiology
Description

Records the electrical signals of the heart via electrode patches. Three types: Resting EKG, Stress/Exercise EKG, and Ambulatory EKG (1-2 day portable monitoring).

10Magnetic Resonance Angiography (MRA)
CategoryDiagnostic Radiology
Description

Uses MRI technology to examine the condition of blood vessels and identify narrow or blocked vessels, performed with or without IV contrast.

11Renal Ultrasound
CategoryDiagnostic Radiology
Description

Ultrasound imaging of the kidneys, renal pelvis, and optionally the bladder to assess renal disease, infection, congenital abnormalities, parenchymal disease, and kidney stones.

12Prostate Ultrasound (TRUS)
CategoryDiagnostic Radiology
Description

Transrectal ultrasound (TRUS) for prostate and seminal vesicle imaging, used for benign prostate enlargement, prostate cancer detection, biopsy guidance, active surveillance, and tumor staging.

13Calcium Scoring (CAC)
CategoryDiagnostic Cardiology
Description

Non-invasive CT scan of the heart that detects the amount of calcium in coronary artery walls as a measure of plaque buildup, using multidetector-row/multi-slice CT technology with low radiation dose and no contrast.

14Radiation Therapy / Oncology Treatment
CategoryOncology Services
Description

Comprehensive radiation therapy services for cancer treatment using advanced equipment in convenient outpatient locations with personalized, patient-focused care.

15Nuclear Medicine
CategoryDiagnostic Radiology
Description

Diagnostic imaging utilizing radioactive tracers to visualize organ function and structure, encompassing PET imaging and other nuclear medicine studies.

16DEXA (Bone Density)
CategoryDiagnostic Radiology
Description

Bone density scanning using dual-energy X-ray absorptiometry to measure bone mineral density and assess osteoporosis risk.

17Partner Solutions
CategoryPartnership Services
Description

A suite of partnership-oriented service offerings including Joint Ventures, Interim & Mobile Solutions, Managed Services, Oncology Services, and Urology Solutions (mobile PET/CT, MRI, radiopharmaceuticals & staffing), enabling hospitals, health systems, and physician groups to access imaging and oncology capabilities without owning equipment.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeTechnology or Integration
Description

Technology partnership for advanced imaging equipment. Akumin AXIS 1.5T MRI uses Siemens Healthineers Magnetom Viato technology, and the Akumin AXIS Drop Trailer features Siemens Healthineers Biograph Trinion PET/CT scanner.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Akumin participates in RadSite's ADI and CBCT Standards Committees to help enhance accreditation programs in advanced diagnostic imaging and promote quality and safety standards.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Akumin

Outpatient Diagnostic Imaging Servicesakumin.com

Akumin Inc. is a U.S. national outpatient diagnostic imaging and radiation therapy provider operating 124 fixed-site centers across 14 states, the nation's largest mobile imaging fleet, and the Akumin AXIS relocatable imaging line, serving 800+ hospitals, health systems, physician groups, and individual patients.

What Akumin does

Akumin Inc. is a U.S. national provider of outpatient diagnostic imaging and radiation therapy services, headquartered in Tampa, Florida, and operating as a privately held company following its delisting from the TSX. The company runs 124 fixed-site outpatient imaging centers across 14 states, the nation's largest mobile imaging fleet, and the Akumin AXIS line of relocatable imaging suites (including a 1.5T MRI and a patent-pending mobile PET/CT Drop Trailer), partnering with more than 800 hospitals, health systems, and physician groups. Service offerings span MRI (wide-bore, open, upright, and specialty exams), PET/CT (including PSMA PET/CT for prostate cancer), CT, digital X-ray, ultrasound (including echocardiography and TRUS), 3D mammography, nuclear medicine, DEXA bone density, MRA, calcium scoring, and EKG, along with radiation therapy/oncology delivered in outpatient settings.

The business is built on a hybrid B2B/B2C model. Akumin generates revenue from per-exam imaging and radiation therapy services billed primarily through insurance reimbursement at its fixed-site centers, from mobile imaging services deployed to partner facilities, and from enterprise partner solutions structured as joint ventures, managed services, interim/mobile arrangements, oncology services, and urology solutions (mobile PET/CT, MRI, radiopharmaceuticals, and staffing). Customer segments are hospitals and health systems seeking to expand imaging capacity without capital outlay, physician groups requiring diagnostic capability for their patients, and individual patients accessing outpatient imaging directly. Supporting infrastructure includes a physician portal for electronic order and results management, an EMR-agnostic interoperability stack (HL7, Direct Messaging, PowerShare cloud image exchange, Athenahealth integration, and lightweight installer tools), and RadSite standards committee participation for accreditation.

Operationally, Akumin has been in a financial restructuring phase: in late 2025, Stonepeak committed a $154.5 million investment to support an exchange offer for 2027 and 2028 senior secured notes, extend maturities, and provide new growth capital, with over 99% of noteholders tendering by the February 2026 early deadline. The company is pairing this balance sheet repair with the commercial launch of the Akumin AXIS relocatable imaging line, deepened technology partnership with Siemens Healthineers, and continued integration into cloud-based EMR and image exchange ecosystems, positioning it as a turnaround-stage national outpatient imaging platform rather than an early-stage growth company.

Akumin firmographics

Firmographics
Name
Akumin
Legal name
Akumin Inc.
Website
https://akumin.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Akumin Inc. is a U.S. national outpatient diagnostic imaging and radiation therapy provider operating 124 fixed-site centers across 14 states, the nation's largest mobile imaging fleet, and the Akumin AXIS relocatable imaging line, serving 800+ hospitals, health systems, physician groups, and individual patients.
Ownership category
akta.pro rank

Akumin industry classification

Industry
Product category
Outpatient Diagnostic Imaging Services
NAICS
Diagnostic Imaging Centers (621512), Ambulatory Health Care Services (621)
SIC
Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)
akta.pro primary industry
Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB)
akta.pro secondary industries
Radiology Imaging Centers (X-ray/CT/MRI/Ultrasound) (HLAFAKAA), Nuclear Medicine Clinical Services & Therapy Centers (HLAIAGAI), Image Exchange, Sharing & Patient/Provider Portals (DICOM/Web) (HLACALAI)

Keywords

  • Outpatient diagnostic imaging
  • Radiation therapy services
  • Medical imaging centers
  • Mobile imaging fleet
  • Oncology treatment services

Where Akumin is headquartered

Location

Headquarters

HQ city
Jenkintown
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Akumin business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

  1. Diagnostic Imaging Services: Revenue generated from providing advanced diagnostic imaging services including MRI, PET/CT, CT, X-ray, Nuclear Medicine, DEXA, and 3D Mammography through fixed-site outpatient centers and mobile units
  2. Radiation Therapy / Oncology Services: Comprehensive oncology and radiation therapy solutions for cancer treatment delivered in outpatient settings
  3. Partner Solutions: Revenue from joint ventures, managed services, interim & mobile solutions, and urology solutions offered to hospitals, health systems, and physician groups
  4. Mobile Imaging Services: Revenue from mobile imaging fleet providing flexible diagnostic imaging solutions across multiple locations

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Akumin product offering

Product offering

Core offering

Akumin owns and operates a national network of 124 outpatient diagnostic imaging centers across 14 US states, complemented by the nation's largest mobile imaging fleet and Akumin AXIS relocatable clinics. The company delivers advanced diagnostic imaging (MRI, PET/CT, CT, X-ray, Nuclear Medicine, DEXA, 3D Mammography) and radiation therapy/oncology services, partnering with more than 800 hospitals, health systems, and physician groups through joint ventures, managed services, and interim & mobile solutions.

Product overview

Akumin is a national provider of outpatient diagnostic imaging and radiation therapy/oncology services, operating a unified platform of owned and/or managed outpatient imaging centers, the nation's largest mobile imaging fleet, and Akumin AXIS relocatable clinics — partnering with over 800 hospitals, health systems, and physician groups. The product portfolio is organized around three core service pillars: Radiology Procedures (MRI/PET-CT/CT/X-ray/Nuclear Medicine/DEXA/3D Mammography), Oncology Treatment (radiation therapy), and Partner Solutions (joint ventures, managed services, interim & mobile solutions, oncology services, urology solutions). Akumin AXIS is the company's relocatable imaging suite sub-brand offering fixed relocatable MRI (1.5T Siemens Healthineers) and the patent-pending Drop Trailer mobile PET/CT unit. Supporting infrastructure includes a Physician Portal for order and results management, PowerShare cloud image exchange integration, and interoperability options spanning HL7, Direct Messaging, Athenahealth EMR, and lightweight installer tools. Akumin also participates in RadSite's accreditation programs for advanced diagnostic imaging quality and safety standards.

Differentiator

Problem solved

Functional benefit

Brands

  • Akumin AXIS: Relocatable imaging suite line featuring mobile MRI and PET/CT units including the Akumin AXIS 1.5T MRI with Siemens Healthineers Magnetom Viato technology and the patent-pending Akumin AXIS Drop Trailer mobile imaging unit.

Products and services

  • Akumin AXIS Relocatable imaging suite line offering mobile and modular imaging solutions, including fixed relocatable 1.5T MRI units and the patent-pending Drop Trailer mobile PET/CT unit with step-free patient access, designed for direct hospital deployment.
  • PET/CT Imaging Positron Emission Tomography and Computed Tomography combined in a single exam, providing both metabolic and anatomical information. Includes standard PET/CT and PSMA PET/CT for prostate cancer detection, offered across fixed-site and mobile/network locations.
  • MRI (Magnetic Resonance Imaging) Diagnostic imaging using radio waves and a strong magnetic field to visualize internal organs without ionizing radiation. Includes Wide-Bore MRI (1.5T-3T), Open MRI, Upright MRI, prostate MRI, cardiac MRI, and NeuroQuant brain MRI analysis.
  • 3D Mammography (Breast Tomosynthesis) FDA-approved breast imaging technology that captures multiple slices of the breast at various angles and reconstructs them into a 3D image, improving cancer detection over standard 2D mammography. Offered as screening and diagnostic mammograms.
  • CT Scan (Computed Tomography) Diagnostic imaging combining X-ray technology with computer processing to generate detailed cross-sectional images of the body for head/neck, chest, abdomen/pelvis, musculoskeletal, oncology, cardiac (CCTA), and low-dose lung screening applications.
  • Digital X-ray General radiography providing quick imaging for chest, abdominal, KUB, neck, hand, joint, and skull exams.
  • Ultrasound Imaging using high-frequency sound waves to create real-time pictures of internal organs and blood vessels, applied in prenatal care, abdominal, pelvic, vascular, cardiac, and procedure guidance contexts.
  • Echocardiography Ultrasound scan of the heart and surrounding blood vessels, including transthoracic (TTE), transesophageal (TEE), Doppler, and color Doppler assessments of blood flow.
  • Electrocardiography (EKG/ECG) Records the electrical signals of the heart via electrode patches. Three types: Resting EKG, Stress/Exercise EKG, and Ambulatory EKG (1-2 day portable monitoring).
  • Magnetic Resonance Angiography (MRA) Uses MRI technology to examine the condition of blood vessels and identify narrow or blocked vessels, performed with or without IV contrast.
  • Renal Ultrasound Ultrasound imaging of the kidneys, renal pelvis, and optionally the bladder to assess renal disease, infection, congenital abnormalities, parenchymal disease, and kidney stones.
  • Prostate Ultrasound (TRUS) Transrectal ultrasound (TRUS) for prostate and seminal vesicle imaging, used for benign prostate enlargement, prostate cancer detection, biopsy guidance, active surveillance, and tumor staging.
  • Calcium Scoring (CAC) Non-invasive CT scan of the heart that detects the amount of calcium in coronary artery walls as a measure of plaque buildup, using multidetector-row/multi-slice CT technology with low radiation dose and no contrast.
  • Radiation Therapy / Oncology Treatment Comprehensive radiation therapy services for cancer treatment using advanced equipment in convenient outpatient locations with personalized, patient-focused care.
  • Nuclear Medicine Diagnostic imaging utilizing radioactive tracers to visualize organ function and structure, encompassing PET imaging and other nuclear medicine studies.
  • DEXA (Bone Density) Bone density scanning using dual-energy X-ray absorptiometry to measure bone mineral density and assess osteoporosis risk.
  • Partner Solutions A suite of partnership-oriented service offerings including Joint Ventures, Interim & Mobile Solutions, Managed Services, Oncology Services, and Urology Solutions (mobile PET/CT, MRI, radiopharmaceuticals & staffing), enabling hospitals, health systems, and physician groups to access imaging and oncology capabilities without owning equipment.

Companies that use Akumin

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Akumin technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

Feature4 records

Akumin partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • Siemens HealthineerscoreTechnology or IntegrationTechnology partnership for advanced imaging equipment. Akumin AXIS 1.5T MRI uses Siemens Healthineers Magnetom Viato technology, and the Akumin AXIS Drop Trailer features Siemens Healthineers Biograph Trinion PET/CT scanner.
  • RadSiteminorStrategic or Co-development PartnerAkumin participates in RadSite's ADI and CBCT Standards Committees to help enhance accreditation programs in advanced diagnostic imaging and promote quality and safety standards.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Akumin competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Akumin social profiles

Digital presence

Akumin financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Akumin leadership team

Management profile

Number of profiles

Profiles4 records

Akumin funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Akumin M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Akumin

What does Akumin do?

Akumin owns and operates a national network of 124 outpatient diagnostic imaging centers across 14 US states, complemented by the nation's largest mobile imaging fleet and Akumin AXIS relocatable clinics. The company delivers advanced diagnostic imaging (MRI, PET/CT, CT, X-ray, Nuclear Medicine, DEXA, 3D Mammography) and radiation therapy/oncology services, partnering with more than 800 hospitals, health systems, and physician groups through joint ventures, managed services, and interim & mobile solutions.

Is Akumin a public or private company?

Akumin is a private company. It is classified as private equity controlled and is currently operating.

When was Akumin founded?

Akumin was founded in 2015. It employs 1,001 to 5,000 people.

Where is Akumin based?

Akumin is headquartered in Jenkintown, United States, in the North America region.

How does Akumin make money?

Four revenue lines are on record. Diagnostic Imaging Services are the primary driver. The others are radiation Therapy / Oncology Services, partner Solutions and mobile Imaging Services.

Does Akumin have an API?

No public API is recorded for Akumin.

What industry is Akumin in?

Akumin's product category is Outpatient Diagnostic Imaging Services. Its primary akta.pro industry code is HLAFAKAB, Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology), with a secondary code of HLAFAKAA, Radiology Imaging Centers (X-ray/CT/MRI/Ultrasound). Its NAICS code is 621512 and its SIC code is 8093.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogAkumin Unveils Newly Renovated Plantation Imaging Center During Open House Celebration with United ImagingAkumin held an open house and ribbon-cutting ceremony at its newly renovated Plantation imaging center, in collaboration with United Imaging. The center features newly installed MRI and PET/CT systems, with a CT system planned for near-future installation. Akumin aims to enhance patient experience through advanced technology and thoughtful design.PR NewswireAkumin Inc. Announces Early Deadline Results and Continued Availability of Total Exchange Consideration Until Expiration TimeAkumin Inc. announced that as of the Early Deadline on February 2, 2026, holders of 100% of the $436.2 million aggregate principal 2027 Notes and 99.97% of the $354.5 million aggregate principal 2028 Notes have validly tendered their Old Notes in the Exchange Offer. The company has received the requisite consents to adopt Proposed Amendments and will enter into Supplemental Indentures, though these amendments will only become operative upon the Settlement Date. The Exchange Offer is scheduled to expire at 5:00 p.m. New York City time on February 18, 2026, with settlement expected within three business days thereafter.PR NewswireAkumin Inc. Commences Exchange Offer and Consent SolicitationAkumin Inc. announced the launch of an exchange offer and consent solicitation to its holders of senior secured notes, aiming to extend debt maturities and reduce debt. The company also expects to fund the transaction with a $154.5 million investment from Stonepeak and will convert or subordinate its revolving credit facility depending on participation levels.Business Wire BlogAkumin Announces Agreement that will Solidify Long-Term Financial Foundation to Support Continued Growth and Patient CareAkumin Inc. has entered into a Support Agreement with noteholders representing over 95% of its outstanding senior secured notes due 2027 and 2028, along with alternative investment firm Stonepeak, to reduce debt, enhance liquidity, and extend debt maturities. Under the agreement, Akumin will launch an exchange offer in January 2026 to issue new senior secured notes due 2031, while Stonepeak has committed to investing approximately $154.5 million of new capital to support the company's long-term business growth. The new notes will accrue cash interest at 9.75%, stepping down to 8.75% upon achieving a specified rating threshold, and the company's existing revolving credit facility of approximately $119 million will either convert to preferred equity or be subordinated depending on tender participation levels.Business Wire BlogAkumin Expands Akumin AXIS™ Line with New 1.5T MRI and Akumin AXIS Drop TrailerAkumin announced two new products in its Akumin AXIS relocatable imaging suite line at the 2025 RSNA annual meeting: the Akumin AXIS 1.5T MRI featuring Siemens Healthineers Magnetom Viato technology and the Akumin AXIS Drop Trailer, a patent-pending mobile imaging unit with Siemens Healthineers Biograph Trinion PET/CT scanner. The Drop Trailer is described as the first design of its kind in the U.S., enabling direct step-free patient access in a mobile environment. Multiple units are already deployed at hospitals across the United States, with Akumin exploring expansion of the Drop Trailer line into additional modalities in 2026.Towards HealthcareU.S. Diagnostic Imaging Services Market Booms 7.04% CAGR by 2034The U.S. diagnostic imaging services market is projected to grow from USD 140.25 billion in 2024 to USD 276.31 billion by 2034, driven by a CAGR of 7.04%. This expansion is fueled by an aging population, rising disease prevalence, and the integration of AI technologies that enhance diagnostic precision and efficiency. Key industry players such as RadNet, Inc., Akumin, Inc., and GE HealthCare are actively expanding operations and forming strategic partnerships to capitalize on these trends.The Globe and MailDiagnostic Imaging Services Market to hit US$ 845.34 Bn by 2032 – Coherent Market Insights | RadNet, Inc., Akumin Inc., Novant HealthThe global diagnostic imaging services market is projected to grow from USD 565.55 billion in 2025 to USD 845.34 billion by 2032, a CAGR of 5.9%. Growth is driven by rising chronic disease prevalence and early-detection demand, while high equipment costs and radiation concerns may limit expansion.PR NewswireAkumin Selects Lunit INSIGHT DBT™ to Enhance Nationwide Breast Imaging ServicesAkumin selected Lunit INSIGHT DBT to enhance breast imaging services nationwide. The AI solution is FDA cleared for 2D and 3D use and is deployed in over 200 imaging centers. Akumin operates over 150 fixed sites and partners with over 1,000 healthcare providers.PR NewswireAkumin Establishes Physician Advisory BoardAkumin Inc. announced the formation of its new Physician Advisory Board (APAB) to advise on innovation, clinical and operational excellence across Radiology, Theranostics, and Radiation Oncology. The inaugural members are Dr. Vijay Rao, David C. Levin Professor and Senior Vice President at Jefferson Health, and Dr. Aytekin Oto, Professor and Dean for Clinical Affairs at the University of Chicago. Akumin, which operates the largest MRI and PET-CT volumes of any healthcare provider in the U.S., stated the board will provide expert clinical guidance to ensure high standards of patient care.Radiology BusinessAkumin’s founder and CEO steps down days after radiology provider completes bankruptcy processAkumin Inc.'s founder and CEO Riadh Zine is stepping down following the company's exit from Chapter 11 bankruptcy, which transferred ownership to lender Stonepeak after deleveraging $470 million in debt. Krishna Kumar, previously president and COO, has been appointed as the new CEO to lead the radiology provider into its next phase of growth. The leadership change follows a period of financial strain caused by heavy debt acquired during major expansions, including the $820 million acquisition of Alliance Healthcare Services.